ABVE-PC, A Drug Combination for Chemotherapy in Cancer Treatment

Doctors include the following drugs in the ABVE-PC combination:

Doxorubicin Hydrochloride (A = Doxorubicin) (Adriamycin)

Bleomycin is a kind of antibiotic.

Vincristine Sulfate (V)

Etoposide is a kind of etoposide. Phosphate

P stands for prednisone.

C stands for cyclophosphamide.

In fact, experts frequently administer chemotherapy as a cocktail of medicines. Because multiple medicines destroy cancer cells in different ways, combinations typically perform better than single treatments.

The Food and Drug Administration (FDA) has authorized each of the medicines in this combination in order to treat cancer or cancer-related disorders.

One can use ABVE-PC to treat:

  • Children with Hodgkin lymphoma.

Doctors also use this combination in conjunction with other medications or therapies, as well as to treat cancers of other kinds.

Defining ABVE-PC

Doxorubicin, bleomycin, vincristine, etoposide, prednisone, and also cyclophosphamide are used in the treatment of high-risk pediatric Hodgkin’s lymphoma in conjunction with radiation therapy.

The most common side effect of PDT is sensitivity to bright lights and sunlight. These reactions, as a result of the PDT light, can show up on the skin where there is an application of the drug. They usually involve redness and a tingling or burning sensation. For a period of time after treatment, you’ll need to be careful to not expose treated areas of your face and scalp to light.

Important: The material on this website on drugs is for educational purposes only. It is not intended to be a replacement for medical advice. This information may not include all of the drug’s probable uses, actions, interactions, or adverse effects, as well as any precautions to take while using it. For additional information regarding your unique medical condition and the usage of this medication, please see your health care provider.